top of page
Veradermics_hero_2023.jpg

OUR FULL WEBSITE IS UNDER CONSTRUCTION AND COMING SOON. IN THE MEANTIME DISCOVER VERADERMICS, INC.

Transforming
Medical Dermatology

ABOUT

Founded by dermatologists, Veradermics leverages its front-line clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. The company has cultivated a pipeline of diverse, first-in-class, single-molecule therapeutics for highly prevalent dermatologic conditions seen in adults and children. Target indications include common warts (verruca vulgaris), alopecia areata, molluscum contagiosum, androgenetic alopecia (pattern hair loss), and atopic dermatitis. Veradermics’ lead product candidate, VDMN, offers a new, patient-friendly, injection-free approach for the treatment of common warts. Veradermics is led by an executive team of board-certified dermatologists supported by a board of directors comprised of recognized biopharmaceutical industry leaders.

Veradermics, Inc. is a medical dermatology company advancing first-in-class therapeutics that address real-world patient needs in under-innovated dermatology markets.

About

Dermatologists Developing First-in-Class Drugs For Dermatology

OUR PIPELINE

We have a rapidly advancing diverse pipeline of first-in-class candidates

Program Indication

MOA Delivery

PRE-IND

PHASE 1

PHASE 2

PHASE 3

VDMN
Common Warts

Candida Antigen Extract
Immunotherapy 
Dissolvable Microarray

VDMC

Molluscum Contagiosum

Topical 
New Chemical Entity
Antiviral

VDAA

Alopecia Areata

Confidential
Topical against 
Clinically Validated Target

VDPHL

Pattern Hair Loss

Confidential 
Oral against 
Clinically Validated Target

VDAD

Atopic Dermatitis

Oral 
New Chemical Entity
Against Clinically Validated Target

Addressing Pervasive Treatment Challenges in Dermatology

molluscum.jpg
Warts.jpg
alopeciaareata.jpg

Veradermics has cultivated a dermatology-focused pipeline of five novel product candidates for large-market conditions seen in adults and children that are overdue for new treatment approaches including common warts, molluscum contagiosum, alopecia areata, androgenetic alopecia (pattern hair loss), and atopic dermatitis.

Connect With Us

To learn more about Veradermics, please complete the form below and we will be in touch.

We appreciate you contacting us, we will get back in touch with you soon!

bottom of page